Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkers
| dc.contributor.author | Cetin, Bulent | |
| dc.contributor.author | Wabl, Chiara A. | |
| dc.contributor.author | Gumusay, Ozge | |
| dc.date.accessioned | 2025-10-16T15:15:08Z | |
| dc.date.issued | 2023 | |
| dc.identifier.doi | 10.2217/imt-2022-0287 | |
| dc.identifier.other | WOS:001002746600001 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/6380 | |
| dc.publisher | TAYLOR \& FRANCIS LTD | |
| dc.source | IMMUNOTHERAPY | |
| dc.subject | biomarker testing | |
| dc.subject | esophagogastric cancer | |
| dc.subject | HER2\\-targeted therapy | |
| dc.subject | immunotherapy | |
| dc.subject | novel immunotherapies | |
| dc.subject | PD\\-L1 | |
| dc.title | Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkers | |
| dc.type | Review |
